Elachista rubella

Last updated

Elachista rubella
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Eukaryota
Kingdom: Animalia
Phylum: Arthropoda
Class: Insecta
Order: Lepidoptera
Family: Elachistidae
Genus: Elachista
Species:
E. rubella
Binomial name
Elachista rubella
Blanchard, 1852

Elachista rubella is a moth in the family Elachistidae. It was described by Blanchard in 1852. [1] It is found in Chile. [2]

Related Research Articles

<span class="mw-page-title-main">MMR vaccine</span> Combined vaccine against measles, mumps, and rubella

The MMR vaccine is a vaccine against measles, mumps, and rubella, abbreviated as MMR. The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least four weeks between the doses. After two doses, 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella. The vaccine is also recommended for those who do not have evidence of immunity, those with well-controlled HIV/AIDS, and within 72 hours of exposure to measles among those who are incompletely immunized. It is given by injection.

<span class="mw-page-title-main">Rubella</span> Human viral disease

Rubella, also known as German measles or three-day measles, is an infection caused by the rubella virus. This disease is often mild, with half of people not realizing that they are infected. A rash may start around two weeks after exposure and last for three days. It usually starts on the face and spreads to the rest of the body. The rash is sometimes itchy and is not as bright as that of measles. Swollen lymph nodes are common and may last a few weeks. A fever, sore throat, and fatigue may also occur. Joint pain is common in adults. Complications may include bleeding problems, testicular swelling, encephalitis, and inflammation of nerves. Infection during early pregnancy may result in a miscarriage or a child born with congenital rubella syndrome (CRS). Symptoms of CRS manifest as problems with the eyes such as cataracts, deafness, as well as affecting the heart and brain. Problems are rare after the 20th week of pregnancy.

<span class="mw-page-title-main">Congenital rubella syndrome</span> Medical condition

Congenital rubella syndrome (CRS) occurs when a human fetus is infected with the rubella virus via maternal-fetal transmission and develops birth defects. The most common congenital defects affect the ophthalmologic, cardiac, auditory, and neurologic systems.

<i>Capsella</i> (plant) Genus of flowering plants in the mustard family

Capsella is a genus of herbaceous annual and biennial plants in the family Brassicaceae. It is a close relative of Arabidopsis, Neslia, and Halimolobos.

<span class="mw-page-title-main">Rubella virus</span> Species of virus

Rubella virus (RuV) is the pathogenic agent of the disease rubella, transmitted only between humans via the respiratory route, and is the main cause of congenital rubella syndrome when infection occurs during the first weeks of pregnancy.

The MMRV vaccine is a combination vaccine which combines the attenuated virus measles, mumps, rubella, and varicella (chickenpox). The MMRV vaccine has similar immunogenicity and overall safety profiles to the MMR vaccine administered with or without the varicella vaccine. The MMRV vaccine is typically given to children between one and two years of age.

Immunization during pregnancy is the administration of a vaccine to a pregnant individual. This may be done either to protect the individual from disease or to induce an antibody response, such that the antibodies cross the placenta and provide passive immunity to the infant after birth. In many countries, including the US, Canada, UK, Australia and New Zealand, vaccination against influenza, COVID-19 and whooping cough is routinely offered during pregnancy.

<span class="mw-page-title-main">Measles vaccine</span> Vaccine used to prevent measles

Measles vaccine protects against becoming infected with measles. Nearly all of those who do not develop immunity after a single dose develop it after a second dose. When the rate of vaccination within a population is greater than 92%, outbreaks of measles typically no longer occur; however, they may occur again if the rate of vaccination decreases. The vaccine's effectiveness lasts many years. It is unclear if it becomes less effective over time. The vaccine may also protect against measles if given within a couple of days after exposure to measles.

<span class="mw-page-title-main">Rubella vaccine</span> Vaccine used to prevent rubella

Rubella vaccine is a vaccine used to prevent rubella. Effectiveness begins about two weeks after a single dose and around 95% of people become immune. Countries with high rates of immunization no longer see cases of rubella or congenital rubella syndrome. When there is a low level of childhood immunization in a population it is possible for rates of congenital rubella to increase as more women make it to child-bearing age without either vaccination or exposure to the disease. Therefore, it is important for more than 80% of people to be vaccinated. By introducing rubella containing vaccines, rubella has been eradicated in 81 nations, as of mid-2020.

Boston exanthem disease is a cutaneous condition that first occurred as an epidemic in Boston in 1951. It is caused by echovirus 16. The disease tends to afflict children more often than adults, although some adults can become infected, and the symptoms have never been fatal. It shows some clinical similarity to Rubella and Human herpesvirus 6

Rubellatoma rubella, common name the reddish mangelia, is a species of sea snail, a marine gastropod mollusk in the family Mangeliidae.

<i>Elachista</i> Genus of moths

Elachista is a genus of gelechioid moths described by Georg Friedrich Treitschke in 1833. It is the type genus of the grass-miner moth family (Elachistidae). This family is sometimes circumscribed very loosely, including for example the Agonoxenidae and Ethmiidae which seem to be quite distinct among the Gelechioidea, as well as other lineages which are widely held to be closer to Oecophora than to Elachista and are thus placed in the concealer moth family Oecophoridae here.

Elachista blancella is a moth in the family Elachistidae. It was described by Traugott-Olsen in 1992. It is found in Turkey.

Elachista wadielhiraensis is a moth in the family Elachistidae. It was described by Traugott-Olsen in 1992. It is found in Libya.

Elachista brachyplectra is a moth in the family Elachistidae. It was described by Edward Meyrick in 1921. It is found on Java and in Sri Lanka and southern India.

<i>Elachista napaea</i> Species of moth

Elachista napaea is a moth in the family Elachistidae. It was described by Philpott in 1930. It is found in New Zealand.

Elachista watti is a moth in the family Elachistidae. It was described by Philpott in 1924. It is found in New Zealand.

Elachista holdgatei is a moth in the family Elachistidae. It was described by John David Bradley in 1965. It is found on the Falkland Islands.

<i>Elachista hookeri</i> Species of moth

Elachista hookeri is a moth in the family Elachistidae. It was described by John S. Dugdale in 1971. It is found in New Zealand, where it has been recorded from the Auckland Islands.

<i>Cephaloziella</i> Genus of liverworts

Cephaloziella is a genus of liverworts. Cephaloziella varians(Gottsche) Steph. is the only liverwort that occurs in the continental Antarctic.

References

  1. Beccaloni, G.; Scoble, M.; Kitching, I.; Simonsen, T.; Robinson, G.; Pitkin, B.; Hine, A.; Lyal, C., eds. (2003). "Elachista rubella". The Global Lepidoptera Names Index . Natural History Museum . Retrieved May 23, 2018.
  2. Elachista at funet